PancreaSeq Molecular Test Outperforms Current Guidelines
The PancreaSeq molecular test accurately classifies pancreatic cysts as potentially cancerous or benign, a large, multi-center study found.
Read MorePosted by Chris Wolski | Oct 5, 2022 | Pancreatic, Sequencing Systems |
The PancreaSeq molecular test accurately classifies pancreatic cysts as potentially cancerous or benign, a large, multi-center study found.
Read MorePosted by Chris Wolski | Oct 5, 2022 | Miscellaneous |
SALSA legislation will help protect labs and patients by addressing the shortcomings of the 2014 Protecting Access to Medicare Act.
Read MorePosted by Andy Lundin | Sep 23, 2022 | Prostate |
A new study investigated genomic biomarkers associated with aggressive disease in African American men with prostate cancer.
Read MorePosted by Andy Lundin | Sep 23, 2022 | Breast |
Invitae released a study recommending genetic testing for those with breast cancer, and showing how testing improves patient outcomes.
Read MorePosted by Andy Lundin | Sep 22, 2022 | Covid 19, Diagnostic Technologies |
An engineered CRISPR-based method that finds RNA from SARS-CoV-2 promises to make testing for COVID and other diseases fast and easy.
Read More